Invention Grant
- Patent Title: Thienopyrimidine inhibitors of atypical protein kinase C
-
Application No.: US16212582Application Date: 2018-12-06
-
Publication No.: US10954251B2Publication Date: 2021-03-23
- Inventor: Bruce D. Dorsey , Keith S. Learn , Emma L. Morris , Gregory R. Ott , Jonathan R. A. Roffey , Christelle N. Soudy , Jason C. Wagner
- Applicant: Cancer Research Technology Limited
- Applicant Address: GB London
- Assignee: Cancer Research Technology Limited
- Current Assignee: Cancer Research Technology Limited
- Current Assignee Address: GB London
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
- Main IPC: C07D495/04
- IPC: C07D495/04 ; C07D495/20 ; C07D495/14 ; C07F7/08 ; C07D519/00
Abstract:
The present application provides a compound of formula (I) or a salt thereof, wherein R1, R2, R3, R4, R5, R6, A, G, M, Q and X are as defined herein. A compound of formula (I) and its salts have a PKC inhibitory activity, and may be used to treat proliferative disorders.
Public/Granted literature
- US20190106433A1 THIENOPYRIMIDINE INHIBITORS OF ATYPICAL PROTEIN KINASE C Public/Granted day:2019-04-11
Information query
